nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data
|
Moullaali, Tom J |
|
|
18 |
9 |
p. 857-864 |
artikel |
2 |
Blood pressure in intracerebral haemorrhage: which variables matter?
|
Ziai, Wendy C |
|
|
18 |
9 |
p. 810-812 |
artikel |
3 |
Charcot's death masks
|
Drouin, Emmanuel |
|
|
18 |
9 |
p. 820 |
artikel |
4 |
Computerised speech and language therapy in post-stroke aphasia
|
Flöel, Agnes |
|
|
18 |
9 |
p. 806-807 |
artikel |
5 |
Correction to Lancet Neurol 2019; 18: 329–31
|
|
|
|
18 |
9 |
p. e8 |
artikel |
6 |
Correction to Lancet Neurol 2019; 18: 653–65
|
|
|
|
18 |
9 |
p. e8 |
artikel |
7 |
Endpoint choice for inclusion body myositis: a step too far?
|
Schmidt, Jens |
|
|
18 |
9 |
p. 807-808 |
artikel |
8 |
Fernando Cendes: targeting epilepsy by improving neuroimaging
|
Kirby, Tony |
|
|
18 |
9 |
p. 819 |
artikel |
9 |
Have your say on the future of European research
|
The Lancet Neurology, |
|
|
18 |
9 |
p. 805 |
artikel |
10 |
Lessons from an unsuccessful therapeutic trial
|
Green, Ari J |
|
|
18 |
9 |
p. 808-810 |
artikel |
11 |
Monitoring traumatic brain injury in China
|
Han, Xueyan |
|
|
18 |
9 |
p. 813 |
artikel |
12 |
Monitoring traumatic brain injury in China – Authors' reply
|
Feng, Jun-Feng |
|
|
18 |
9 |
p. 813-814 |
artikel |
13 |
Ocrelizumab for primary progressive multiple sclerosis
|
Adler, Amanda I |
|
|
18 |
9 |
p. 816-817 |
artikel |
14 |
Parkinson's disease in the Western Pacific Region
|
Lim, Shen-Yang |
|
|
18 |
9 |
p. 865-879 |
artikel |
15 |
Pathophysiology, prevention, and treatment of medication overuse headache
|
Diener, Hans-Christoph |
|
|
18 |
9 |
p. 891-902 |
artikel |
16 |
Recent developments in drug-induced movement disorders: a mixed picture
|
Factor, Stewart A |
|
|
18 |
9 |
p. 880-890 |
artikel |
17 |
Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial
|
Hanna, Michael G |
|
|
18 |
9 |
p. 834-844 |
artikel |
18 |
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial
|
Cadavid, Diego |
|
|
18 |
9 |
p. 845-856 |
artikel |
19 |
Self-managed, computerised speech and language therapy for patients with chronic aphasia post-stroke compared with usual care or attention control (Big CACTUS): a multicentre, single-blinded, randomised controlled trial
|
Palmer, Rebecca |
|
|
18 |
9 |
p. 821-833 |
artikel |
20 |
The neurology of the Cuban “sonic attacks”
|
Popkirov, Stoyan |
|
|
18 |
9 |
p. 817-818 |
artikel |
21 |
The risks and uses of dietary supplements
|
Schneider, Lon S |
|
|
18 |
9 |
p. 814 |
artikel |
22 |
The risks and uses of dietary supplements
|
Balestrino, Maurizio |
|
|
18 |
9 |
p. 814-815 |
artikel |
23 |
Valentina Garibotto
|
|
|
|
18 |
9 |
p. 820 |
artikel |